An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21 days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer

No Thumbnail Available
Authors
Rose, Peter G.
Monk, Bradley J.
Provencher, Diane
Hartney, Jean
Legenne, Philippe
Lane, Stephen
Issue Date
2011
Type
Journal Article
Language
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Description
Citation
Rose, Peter G.; Monk, Bradley J.; Provencher, Diane; Hartney, Jean; Legenne, Philippe; Lane, Stephen. An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21 days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer. Gynecologic oncology. 2011, JAN. 120(1):38-42.
Publisher
License
Journal
Volume
Issue
URI
http://hdl.handle.net/10504/60000
PubMed ID
21055798
DOI
ISSN
0090-8258
1095-6859
EISSN
Collections
Faculty Bibliography Database